Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Phase 1
86
about 1.6 years
12+
8 sites in CA, CO, IL +3
What this study is about
This trial is testing a treatment for atopic dermatitis. It compares ShA9 topical gel to placebo, and also looks at the safety of ShA9 when used with topical corticosteroids.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Clobetasol Ointment
- 2.Take Fluocinonide Ointment
- 3.Take Hydrocortisone Ointment
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
clobetasol, CARDIOVASCULAR SYSTEM, hydrocortisone
topical, injection (Injection)
Primary: Serious and non-serious treatment-emergent adverse events (TEAEs) related or possibly related to study treatment.
Secondary: Change in Pruritus Numeric Rating Scale (NRS) score., Serious and non-serious TEAEs related or possibly related to study treatment.
Dermatology